1487 related articles for article (PubMed ID: 26235541)
41. [Transjugular intrahepatic portosystemic shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation].
Han GH; Meng XJ; Yin ZX; Wang JH; He CY; Liang J; Guo XG; Liu J; Ding L; Wu KC; Fan DM
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1549-52. PubMed ID: 19953883
[TBL] [Abstract][Full Text] [Related]
42. Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization.
Chen S; Li X; Wei B; Tong H; Zhang MG; Huang ZY; Cao JW; Tang CW
Radiology; 2013 Sep; 268(3):900-6. PubMed ID: 23657891
[TBL] [Abstract][Full Text] [Related]
43. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems.
Ganger DR; Klapman JB; McDonald V; Matalon TA; Kaur S; Rosenblate H; Kane R; Saker M; Jensen DM
Am J Gastroenterol; 1999 Mar; 94(3):603-8. PubMed ID: 10086638
[TBL] [Abstract][Full Text] [Related]
44. [Effect of transjugular intrahepatic portosystemic shunt for variceal bleeding in hepatocellular carcinoma patients with portal vein thrombosis].
Chung WJ; Jang BK; Park KS; Cho KB; Hwang JS; Ahn SH; Kim YH; Kim YH; Kim YJ
Korean J Hepatol; 2005 Jun; 11(2):157-63. PubMed ID: 15980674
[TBL] [Abstract][Full Text] [Related]
45. Second prophylaxis of variceal bleeding in cirrhotic patients with a high HVPG.
Zhang M; Wang G; Zhao L; Wu Z; Zhang W; Zhang C
Scand J Gastroenterol; 2016 Dec; 51(12):1502-1506. PubMed ID: 27379704
[TBL] [Abstract][Full Text] [Related]
46. Techniques and long-term effects of transjugular intrahepatic portosystemic shunt on liver cirrhosis-related thrombotic total occlusion of main portal vein.
Wang L; He F; Yue Z; Zhao H; Fan Z; Zhao M; Qiu B; Yao J; Lin Q; Dong X; Liu F
Sci Rep; 2017 Sep; 7(1):10868. PubMed ID: 28883536
[TBL] [Abstract][Full Text] [Related]
47. Outcomes of transjugular intrahepatic portosystemic shunt creation for flow-enabled dissolution of spleno-mesenterico-portal venous thrombosis.
Lakhoo J; Gaba RC
Diagn Interv Imaging; 2016 Nov; 97(11):1085-1093. PubMed ID: 27481577
[TBL] [Abstract][Full Text] [Related]
48. Transjugular Intrahepatic Portosystemic Shunt and Thrombectomy (TIPS-Thrombectomy) for Symptomatic Acute Noncirrhotic Portal Vein Thrombosis.
Shalvoy MR; Ahmed M; Weinstein JL; Ramalingam V; Malik MS; Ali A; Shenoy-Bhangle AS; Curry MP; Sarwar A
J Vasc Interv Radiol; 2023 Aug; 34(8):1373-1381.e3. PubMed ID: 37182668
[TBL] [Abstract][Full Text] [Related]
49. Using transjugular intrahepatic portosystemic shunt as the first-line therapy in secondary prophylaxis of variceal hemorrhage.
Liu J; Shi Q; Xiao S; Zhou C; Zhou B; Yuan F; Zheng C; Lin S; Qian K; Feng G; Xiong B
J Gastroenterol Hepatol; 2020 Feb; 35(2):278-283. PubMed ID: 31222830
[TBL] [Abstract][Full Text] [Related]
50. Portal Vein Thrombosis in Patients With Cirrhosis Undergoing Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors, Warfarin Efficacy, and Clinical Outcomes.
Yue-Meng W; Li YH; Wu HM; Yang J; Yang LH; Xu Y
Clin Appl Thromb Hemost; 2018 Apr; 24(3):462-470. PubMed ID: 28110540
[TBL] [Abstract][Full Text] [Related]
51. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone versus TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study.
Xiao T; Chen L; Chen W; Xu B; Long Q; Li R; Li L; Peng Z; Fang D; Wang R
J Clin Gastroenterol; 2011 Aug; 45(7):643-50. PubMed ID: 21301360
[TBL] [Abstract][Full Text] [Related]
52. Association of Nonmalignant Portal Vein Thrombosis and Outcomes after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis.
Lv Y; He C; Wang Z; Guo W; Wang J; Bai W; Zhang L; Wang Q; Liu H; Luo B; Niu J; Li K; Tie J; Yin Z; Fan D; Han G
Radiology; 2017 Dec; 285(3):999-1010. PubMed ID: 28682164
[TBL] [Abstract][Full Text] [Related]
53. Comparison of long-term outcomes of splenectomy with periesophagogastric devascularization and transjugular intrahepatic portosystemic shunt in treating cirrhotic portal hypertension patients with recurrent variceal bleeding.
Zhu W; Wang X; Lv Y; Chen H; Chen X; Li X; Zhu S; Lin Z; Wang G
Langenbecks Arch Surg; 2023 May; 408(1):215. PubMed ID: 37247018
[TBL] [Abstract][Full Text] [Related]
54. Association of nonmalignant portal vein thrombosis and clinical outcomes in patients with cirrhosis and acute variceal bleeding: a multicenter observational study.
Lv Y; Bai W; Zhu X; Xue H; Zhao J; Zhuge Y; Sun J; Zhang C; Ding P; Jiang Z; Zhu X; Ren W; LiZhang YK; Zhang W; Li K; Wang Z; Luo B; Li X; Yuan J; Yang Z; Guo W; Xia D; Xie H; Yang C; Pan Y; Yin Z; Fan D; Han G
Hepatol Int; 2023 Oct; 17(5):1192-1204. PubMed ID: 37258989
[TBL] [Abstract][Full Text] [Related]
55. Percutaneous Mesocaval Shunt Creation in a Patient with Chronic Portal and Superior Mesenteric Vein Thrombosis.
Bercu ZL; Sheth SB; Noor A; Lookstein RA; Fischman AM; Nowakowski FS; Kim E; Patel RS
Cardiovasc Intervent Radiol; 2015 Oct; 38(5):1316-9. PubMed ID: 25189666
[TBL] [Abstract][Full Text] [Related]
56. Radiation exposure during transjugular intrahepatic portosystemic shunt creation in patients with complete portal vein thrombosis or portal cavernoma.
Miraglia R; Maruzzelli L; Cannataci C; Gerasia R; Mamone G; Cortis K; Cimò B; Petridis I; Volpes R; Luca A
Radiol Med; 2020 Jul; 125(7):609-617. PubMed ID: 32072390
[TBL] [Abstract][Full Text] [Related]
57. Warfarin prevented de novo portal vein thrombosis after transjugular intrahepatic portosystemic shunt: A retrospective study.
Zhang L; Huan H; Tong H; Wei B; Wang Z; Liu C; Wu H
Medicine (Baltimore); 2020 Jan; 99(2):e18737. PubMed ID: 31914090
[TBL] [Abstract][Full Text] [Related]
58. Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Technical Considerations.
Thornburg B; Desai K; Hickey R; Kulik L; Ganger D; Baker T; Abecassis M; Lewandowski RJ; Salem R
Tech Vasc Interv Radiol; 2016 Mar; 19(1):52-60. PubMed ID: 26997089
[TBL] [Abstract][Full Text] [Related]
59. Comparing the predictive ability of portoatrial and portocaval gradient after transjugular intrahepatic portosystemic shunt creation for variceal rebleeding.
Ma L; Liu Y; Yan Z; Zhang W; Zhang Z; Yang M; Yu J; Zhou X; Chen S; Wang J; Ma J; Luo J
J Gastroenterol; 2023 May; 58(5):494-502. PubMed ID: 36892638
[TBL] [Abstract][Full Text] [Related]
60. Transjugular intrahepatic collateral-systemic shunt is effective for cavernous transformation of the portal vein with variceal bleeding.
Tie J; Gou X; He C; Li K; Yuan X; Jia W; Niu J; Han N; Xu J; Zhu Y; Wang W
Hepatol Int; 2023 Aug; 17(4):979-988. PubMed ID: 37097537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
